Gorter A, Meri S
Leiden University Medical Center, Dept of Pathology, Building 1, L1Q, PO Box 9600, 2300 RC Leiden, The Netherlands.
Immunol Today. 1999 Dec;20(12):576-82. doi: 10.1016/s0167-5699(99)01537-6.
Membrane-bound complement regulatory proteins (mCRPs) play an important role in the protection of cells from complement-mediated injury. It is now apparent that malignant tumor cells also express these proteins to escape complement attack. Here, Arko Gorter and Seppo Meri discuss the implications of complement resistance for the immunotherapeutic treatment of solid tumors with monoclonal antibodies.
膜结合补体调节蛋白(mCRP)在保护细胞免受补体介导的损伤中发挥着重要作用。现在很明显,恶性肿瘤细胞也表达这些蛋白以逃避补体攻击。在这里,阿尔科·戈特和塞波·梅里讨论了补体抗性对实体瘤单克隆抗体免疫治疗的影响。